KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Long-Term Deferred Tax (2016 - 2018)

Historic Long-Term Deferred Tax for Idexx Laboratories (IDXX) over the last 3 years, with Q1 2018 value amounting to $9.8 million.

  • Idexx Laboratories' Long-Term Deferred Tax rose 6742.8% to $9.8 million in Q1 2018 from the same period last year, while for Mar 2018 it was $9.8 million, marking a year-over-year increase of 6742.8%. This contributed to the annual value of $7.7 million for FY2017, which is 3488.7% up from last year.
  • As of Q1 2018, Idexx Laboratories' Long-Term Deferred Tax stood at $9.8 million, which was up 6742.8% from $7.7 million recorded in Q4 2017.
  • In the past 5 years, Idexx Laboratories' Long-Term Deferred Tax ranged from a high of $9.8 million in Q1 2018 and a low of $5.7 million during Q4 2016
  • Its 3-year average for Long-Term Deferred Tax is $7.3 million, with a median of $7.2 million in 2017.
  • In the last 5 years, Idexx Laboratories' Long-Term Deferred Tax skyrocketed by 3488.7% in 2017 and then skyrocketed by 6742.8% in 2018.
  • Over the past 3 years, Idexx Laboratories' Long-Term Deferred Tax (Quarter) stood at $5.7 million in 2016, then soared by 34.89% to $7.7 million in 2017, then grew by 27.6% to $9.8 million in 2018.
  • Its last three reported values are $9.8 million in Q1 2018, $7.7 million for Q4 2017, and $7.9 million during Q3 2017.